Selected article for: "previously report and receptor binding"
Author: Angelo Virgilio Paradiso; Simona De Summa; Daniela Loconsole; Vito Procacci; Anna Sallustio; Francesca Centrone; Nicola Silvestris; Vito Cafagna; Giuseppe De Palma; Antonio Tufaro; Vito Garrisi; Maria Chironna
Title: Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR
  • Document date: 2020_4_6
    • ID: ilxd0ih9_7
    Snippet: In the previously mentioned report by Singapore National University, an immunoassay described as with available information regarding sensitivity and specificity is Viva-Diag TM kit produced by Jiangsu Medomics Medical Technologies kit (https://www.vivachek.com/vivachek/English/prods/prod-covid19.html) which, according to the preliminary data available (6), may be a potential candidate for reliable and rapid (15 minutes) testing. The test has bee.....
    Document: In the previously mentioned report by Singapore National University, an immunoassay described as with available information regarding sensitivity and specificity is Viva-Diag TM kit produced by Jiangsu Medomics Medical Technologies kit (https://www.vivachek.com/vivachek/English/prods/prod-covid19.html) which, according to the preliminary data available (6), may be a potential candidate for reliable and rapid (15 minutes) testing. The test has been reported to be based on the utilization of Anti-human IgG and anti IgM against the recombinant antigen representing the Receptor-Binding Domain of the COVID-19 spike protein.

    Search related documents:
    Co phrase search for related documents
    • available information and recombinant antigen: 1, 2, 3, 4, 5, 6
    • available information and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • available information and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Jiangsu Medomics Medical Technologies kit and Medical Technologies kit: 1
    • Jiangsu Medomics Medical Technologies kit and Medomics Medical Technologies kit: 1
    • Jiangsu Medomics Medical Technologies kit and TM kit: 1
    • Medical Technologies kit and Medomics Medical Technologies kit: 1
    • Medical Technologies kit and TM kit: 1
    • Medomics Medical Technologies kit and TM kit: 1
    • potential candidate and recombinant antigen: 1, 2, 3
    • potential candidate and specificity sensitivity: 1, 2, 3
    • potential candidate and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • recombinant antigen and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • recombinant antigen and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • specificity sensitivity and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • specificity sensitivity and TM kit: 1, 2